ADMP   $0.78  1.50% Market Closed

Adamis Pharmaceuticals Corp
Total Cash 640.25K
totalCashPerShare 0.068
EBITDA -17.79M
Total Debt 332.44K
quickRatio 0.044
currentRatio 0.23
Total Revenue 5.02M
debtToEquity
Revenue/Share 2.222
ROA -1.04495
ROE
grossProfits -1.43M
freeCashflow -1.71M
operatingCashflow -13.14M
earningsGrowth
revenueGrowth -0.826
grossMargins -0.2315
ebitdaMargins 0.0
operatingMargins -3.7361999
profitMargins 0.0
enterpriseValue 7.28M
forwardPE
floatShares 9.14M
sharesOutstanding 9.36M
sharesShort 98.94K
sharesShortPriorMonth 57.65K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.08%
heldPercentInstitutions 0.17%
Short Ratio help_outline 0.02%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -4.238
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -23.86M
trailingEps -10.14%
forwardEps -0.08%
enterpriseToEbitda -0.41
lastDividendValue
lastDividendDate
currentQuarterEstimate 3Q 2022
institutionsCount 43
lastUpdated Nov. 9, 2023, 5:29 p.m.